Related Experiment Video
Updated: Jul 2, 2026

09:55
All-optical Mechanobiology Interrogation of Yes-associated Protein in Human Cancer and Normal Cells using a Multi-functional System
Published on: December 20, 2021
Expression of Yes-associated protein in common solid tumors
Angela A Steinhardt1, Mariana F Gayyed, Alison P Klein
1Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21231, USA.
Human Pathology
|August 16, 2008
Summary
The Hippo pathway
Area of Science:
- Cellular biology and cancer research.
- Investigating the Hippo signaling pathway and its role in cancer development.
Background:
- The Hippo signaling pathway regulates cell growth, division, and apoptosis.
- Yes-associated protein (YAP) is the nuclear effector of this pathway.
- YAP gene amplification (11q22) is linked to several human tumors.
Purpose of the Study:
- To determine YAP expression in four common malignant tumors.
- To compare YAP expression in normal tissues versus cancerous tissues.
Main Methods:
- Evaluated YAP expression intensity and distribution in normal and malignant tissues.
- Examined colonic adenocarcinoma, lung adenocarcinoma, ovarian serous cystadenocarcinoma, and ductal carcinoma of the breast.
- Scored nuclear and cytoplasmic YAP expression as negative, low, or high.
Main Results:
- Found focal YAP expression in normal tissue progenitor and reparative cells.
- Observed strong, diffuse nuclear and cytoplasmic YAP expression in colon, lung, and ovarian adenocarcinomas.
- Ductal carcinoma of the breast showed different YAP expression patterns (not detailed).
Conclusions:
- The Hippo pathway exhibits distinct YAP expression patterns in normal versus cancerous colon, lung, and ovarian tissues.
- YAP activation may be involved in normal tissue homeostasis and frequently activated in these three common cancers.
- Suggests YAP's role as a potential oncogenic pathway in these malignancies.
Related Concept Videos
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

